Latest Health News

New Murchison Gold Limited's Crown Prince Gold Mine sustained robust production with 15,455 ounces sold in the June quarter, while the Garden Gully Gold Project’s resource estimate jumped 47% to 359,000 ounces. Mining has now commenced at the Cloudkicker open pit, supporting growth and operational flexibility.

Tivan Limited has appointed Robert Gerrard as CEO (Australia), elevated Dr Ellin Lede to the Board, and named Brendon Nicol as CTO to sharpen its leadership as it moves towards key project milestones at Speewah and Molyhil.

Truscott Mining (ASX: TRM) is pressing ahead at its Tennant Creek projects, updating its flagship Westminster resource and confirming structural gold mineralisation from recent drilling. Expansion plans across North Tennant and Barkly projects underpin a disciplined, multi-year exploration strategy.

Resources & Energy Group Limited (ASX:REZ) has formalised a joint venture with Rembrandt Mining to commence gold production at its Maranoa deposit, with Rembrandt funding all capital expenditure and REZ retaining full ownership and legal operator status.

Coast Entertainment has unlocked a major milestone with Queensland Government approval for its Coomera landholding development, while reporting robust FY26 trading with double-digit growth in ticket sales and revenue.

PainChek appoints seasoned US medtech executive Karen Holzberger as CEO to spearhead growth following FDA clearance and major US contracts.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

BCI Minerals has reached 85% construction completion at its Mardie Salt Operation and Potash Project, with salt crystallisation commenced and 49,000 tonnes produced. The project remains fully funded and on budget, progressing towards first salt shipment in early 2027, weather permitting.

Marlin Global's portfolio delivered a 2.0% gross return in Q2 2026, driven by rebounds in ICON and semiconductor holdings, but lagged a strong US market rally led by AI and chip stocks.

LTR Pharma has formalised its US commercialisation strategy by signing a definitive agreement with telehealth leader Shed, targeting at least 150,000 ROXUS units in the first year through digital men’s health platforms.

Volt Resources’ Ukrainian subsidiary Zavalievsky Graphite is launching a new graphite production campaign in July 2026, supported by firm European sales contracts worth around €377,000.

Livestock Improvement Corporation reported a 6.7% revenue increase to NZD 314.8 million for FY26, but net profit after tax fell 30.4% to NZD 21.3 million due to significant technology investments. The co-operative declared a 12.26 cent dividend, maintaining strong underlying earnings and a debt-free balance sheet.